Genetic predictors of severe skin toxicity in stage III colon cancer patients treated with cetuximab: NCCTG N0147 (Alliance)

BACKGROUND: Cetuximab, an epidermal growth factor receptor inhibitor used to treat multiple cancer types including colon cancer, causes severe skin toxicity in 5-20% of patients, leading to decreased quality of life and treatment delays. Our understanding of which patients have an increased risk of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Epidemiol Biomarkers Prev
Main Authors: Labadie, Julia D., Hua, Xinwei, Harrison, Tabitha A., Banbury, Barbara L., Huyghe, Jeroen R., Sun, Wei, Shi, Qian, Yothers, Greg, Alberts, Steven R., Sinicrope, Frank A., Goldberg, Richard M., George, Thomas J., Penney, Kathryn L., Phipps, Amanda I., Cohen, Stacey A., Peters, Ulrike, Chan, Andrew T., Newcomb, Polly A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7909617/
https://ncbi.nlm.nih.gov/pubmed/33203692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-20-1274
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados